Chromogranin A is a T cell antigen in human type 1 diabetes. - Wikidata - awgldk - TriplyDB

Chromogranin A is a T cell antigen in human type 1 diabetes.

Chromogranin A is a T cell antigen in human type 1 diabetes.

http://www.wikidata.org/entity/Q37716863

about

Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis T cell epitopes and post-translationally modified epitopes in type 1 diabetes Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes Immunogenetics of type 1 diabetes mellitus Environmental risk factors for type 1 diabetes Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetes.Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.The beta-cell in type 1 diabetes: What have we learned from proteomic studies?β cell ER stress and the implications for immunogenicity in type 1 diabetes.Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.Chromogranin A as biomarker in diabetes.Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity.Understanding type 1 diabetes through proteomics.Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes.Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.Autoreactive T cells in type 1 diabetes.Understanding Autoimmune Diabetes through the Prism of the Tri-Molecular Complex.Chromogranin-A Regulates Macrophage Function and the Apoptotic Pathway in Murine DSS colitis.Autoantibodies to chromogranin A are potential diagnostic biomarkers for non-small cell lung cancer.Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers.The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis

P2860

Q26750714-E40C0671-BDB2-4445-8010-673AC1EA7094 Q26787014-5321004D-213F-4E8F-BAB7-5F3936DE3CD9 Q28080791-4252160A-7427-4B9A-B914-22F61C6A9756 Q28084487-F29977E0-07FA-4D9A-A58E-7FEDACECA3A2 Q28087365-A5BE0E14-A248-46A1-A3D9-C5C1B957D5E3 Q28276366-EA2908CF-82DF-4D7F-A6C5-B4CB4F90134E Q35004357-A42915B9-178F-4BA0-B97C-0C582A12E880 Q36117948-F084BCC2-C291-41EA-A18C-703A278C20CC Q36387060-E6DD8A6B-CDA4-4486-A753-B3143676024A Q36945852-8C193A91-B4B5-4B17-A8BE-0AC95DD3E263 Q36995345-9607F2BB-D4ED-451C-B627-74A9C74FA683 Q37698306-403E2F01-7F33-459A-B652-1BFAD11B7DE8 Q38340362-0C0B39C8-3F88-48DC-96DA-289F75B013F4 Q38637035-6779D6A8-8792-482B-BD9C-01075D790C08 Q38771484-9E0802E9-962A-49B0-AAE0-3CAEAF2AE8FA Q38946141-77326261-F1C2-4DC6-A1E6-68F4EC629A0B Q38950132-9EC69AFB-D846-4C1F-B521-5B0D8F0162E2 Q39147191-BD2941D9-903A-4088-A007-E6EFB712C7E2 Q39398068-CAF23CD8-F954-4804-B815-76625B279797 Q42369799-4CFCBF7B-DE29-4C23-A246-97F555C258D1 Q45048293-D955235F-4DEE-4E21-B3B6-A607F61B8D22 Q47093542-73D2A153-B0FC-4C9C-A594-A6FF842F720B Q47234002-7547D7FC-C0E5-4B64-B401-E946D5998811 Q48004838-02E659AC-2514-460F-B5B4-E93B175252B1 Q49269317-6341DC51-9299-44DC-8DB4-9A61AC89DFEC Q49604394-53354654-24BD-427A-A4EF-B623AE2F4681 Q53206465-B1EE5ADA-18BE-4BB5-AFDE-15FE76ED3875 Q55224664-6529C0EF-ACAA-456C-ADD3-1C111DD09434 Q58701209-725A4C6D-4E8C-4155-8DE6-A2F3F51E949A

P2860

Chromogranin A is a T cell antigen in human type 1 diabetes.

http://www.wikidata.org/entity/Q37716863

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Chromogranin A is a T cell antigen in human type 1 diabetes.

@en

Chromogranin A is a T cell antigen in human type 1 diabetes.

@nl

type

label

Chromogranin A is a T cell antigen in human type 1 diabetes.

@en

Chromogranin A is a T cell antigen in human type 1 diabetes.

@nl

prefLabel

Chromogranin A is a T cell antigen in human type 1 diabetes.

@en

Chromogranin A is a T cell antigen in human type 1 diabetes.

@nl

P1433

Q37716863-171C864F-9A86-40EB-8094-CA4767077799

P1476

Q37716863-D256A8CD-7366-43A0-90D5-204CA5EF8DA0

P2093

Q37716863-31995C0D-6A1A-4D1B-9DFC-B8EA120C6DD6

Q37716863-5C36FE46-1BA7-4BFC-BFB6-9700326E47ED

Q37716863-85DF85CB-2866-4FE9-91D8-FAD4556172B2

Q37716863-90B29E6D-E24D-4DC2-8013-7D2B88851DFE

Q37716863-9CCE3FCE-EBB4-4105-A43C-EBC9CEEEE428

Q37716863-B9544897-A611-46D0-9CC9-3E979553F146

Q37716863-EC22326A-4F1D-468D-993C-EE2EFA218CD4

P2860

Q37716863-0B2BB537-A39C-48DD-A452-B93AD43DBF02

Q37716863-16BABA3C-7956-4F77-8EA5-89F79560F1C7

Q37716863-1DA9349C-5F28-4752-9060-AB2F29A49EF7

Q37716863-1EA616A1-2FAE-4F7C-871A-054C529697A3

Q37716863-36120DA7-D572-4F4D-B036-048C434B55B9

Q37716863-3DF91634-29C8-4D28-8E4F-F1D8D1B670D8

Q37716863-83E29970-3830-406F-9962-4ADAA0DAF268

Q37716863-882248FB-BDFB-4D84-BA29-C66BF218C79B

Q37716863-887C7673-4BAF-4199-BDB9-A9B627A5B5D7

Q37716863-965E7892-2E65-40C1-8635-9C0C7C21F3D1

P304

Q37716863-A12D5090-930C-455C-898B-776C75142F6D

P31

Q37716863-F59D0CDD-14A9-409D-A2C2-ACCDA96DF5EB

P356

Q37716863-5C21F3AA-0D98-4358-8C3D-9491C2AAF947

P478

Q37716863-1C5F62D7-84D5-4460-9289-31EB98D6AF4A

P50

Q37716863-3E25B05F-3136-4E3E-89BC-9520DFD2429A

Q37716863-D3ACA826-D066-4A70-8ED2-29A3D4EEB295

P577

Q37716863-05E73648-0683-4F4A-ABF0-98BBDE033668

P698

Q37716863-BDD656D5-919F-458C-A4AC-0EA69100CE45

P921

Q37716863-48591B12-4325-4E69-8EDC-1EA27A901D80

P932

Q37716863-FE0286B1-4354-4062-997D-FA7BA4726A25

P356

J.JAUT.2013.10.003

P1433

Journal of Autoimmunity

P1476

Chromogranin A is a T cell antigen in human type 1 diabetes.

@en

P2093

Gabrielle Cook

http://www.w3.org/2001/XMLSchema#string

Kathryn Haskins

http://www.w3.org/2001/XMLSchema#string

Lisa Fitzgerald-Miller

http://www.w3.org/2001/XMLSchema#string

Marian R Rewers

http://www.w3.org/2001/XMLSchema#string

Peter A Gottlieb

http://www.w3.org/2001/XMLSchema#string

Rebecca Wagner

http://www.w3.org/2001/XMLSchema#string

Thomas Delong

http://www.w3.org/2001/XMLSchema#string

P2860

Chromogranin A is an autoantigen in type 1 diabetes

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour

Type I diabetes mellitus. A chronic autoimmune disease.

The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases.

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

Immune therapy for autoimmune diseases.

A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin.

Diabetogenic T-cell clones recognize an altered peptide of chromogranin A.

ICA512 autoantibody radioassay.

P304

38-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAUT.2013.10.003

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Rocky Lee Baker

Aaron W. Michels

P577

2013-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24239002

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3995825

http://www.w3.org/2001/XMLSchema#string